IPOTwo More S-1s Land: Enhanced Group, Serina TherapeuticsEnhanced Group filed a new S-1 on August 25 while biotech Serina Therapeutics registered up to 12.5 million shares for sale to Roth Principal Investments, two more entries in this week's dense small-cap SEC filing pipeline.Aug 25, 2026BY THE NUMBERS